E-LIB Suche - Ergebnisse für: Idos, Gregory E.

1

O06: Penetrance and prevalence of CDKN2A pathogenic variant..:

Gima, Lauren ; Fujii, Christina ; Restrepo, Michael...
Genetics in Medicine Open. 2 (2024) - p. 100941 , 2024

Link: https://doi.org/10.1016/..

2

Differences in Tumor-Associated T cell receptor repertoires..:

Tsai, Ya-Yu ; Nair, Kanika G ; Barot, Shimoli V...
JNCI: Journal of the National Cancer Institute. , 2024

Link: https://doi.org/10.1093/..

3

Sa1168 PREVALENCE AND PENETRANCE OF SPINK1 PATHOGENIC VARIA..:

Reyes, Kathryn ; Alcantara, Jasmine ; Chitre, Anuja Anil...
Gastroenterology. 166 (2024) 5 - p. S-370 , 2024

Link: https://doi.org/10.1016/..

4

Germline genetic regulation of the colorectal tumor immune ..:

Schmit, Stephanie L. ; Tsai, Ya-Yu ; Bonner, Joseph D....
BMC Genomics. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

Family communication of cancer genetic test results in an e..:

Hodan, Rachel ; Picus, Miles ; Stanclift, Caroline...
Journal of Community Genetics. , 2024

Link: https://doi.org/10.1007/..

6

Severe Immune-Mediated Colitis Induced by Checkpoint Inhibi..:

Lee, Rachel V ; Melstrom, Kurt A ; Mannan, Rifat..
Cureus. , 2023

Link: https://doi.org/10.7759/..

7

Clinical implications of conflicting variant interpretation..:

Zukin, Elyssa ; Culver, Julie O. ; Liu, Yuxi...
Genetics in Medicine. 25 (2023) 7 - p. 100837 , 2023

Link: https://doi.org/10.1016/..

8

Heterozygote advantage at HLA class I and II loci and reduc..:

Tsai, Ya-Yu ; Qu, Chenxu ; Bonner, Joseph D....
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

The precede consortium: A longitudinal international cohort..:

García García de Paredes, A. ; Katona, B. ; Zogopoulos, G....
Pancreatology. 23 (2023) 7 - p. e2 , 2023

Link: https://doi.org/10.1016/..

10

Cancer surveillance for transgender and gender diverse pati..:

Hodan, Rachel ; Rodgers-Fouche, Linda ; Chittenden, Anu...
Familial Cancer. 22 (2023) 4 - p. 437-448 , 2023

Link: https://doi.org/10.1007/..

11

MyLynch: A Patient-Facing Clinical Decision Support Tool fo..:

Knapp, Stephen T. ; Revette, Anna ; Underhill-Blazey, Meghan...
Cancers. 15 (2023) 2 - p. 391 , 2023

Link: https://doi.org/10.3390/..

12

Heterozygote advantage at HLA class I and II loci and reduc..:

Ya-Yu Tsai ; Chenxu Qu ; Joseph D. Bonner...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268117/full. , 2023

Link: https://doi.org/10.3389/..

13

Heterozygote advantage at HLA class I and II loci and reduc..:

Tsai, Ya-Yu ; Qu, Chenxu ; Bonner, Joseph D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627840/. , 2023

Link: http://www.ncbi.nlm.nih...

14

MyLynch: A Patient-Facing Clinical Decision Support Tool fo..:

Stephen T. Knapp ; Anna Revette ; Meghan Underhill-Blazey...
Tumor Microenvironment. , 2023

Link: https://doi.org/10.3390/..

15

MyLynch: A Patient-Facing Clinical Decision Support Tool fo..:

Stephen T. Knapp ; Anna Revette ; Meghan Underhill-Blazey...
https://www.mdpi.com/2072-6694/15/2/391. , 2023

Link: https://doi.org/10.3390/..